SCHEDULE 13G/A: Bigger Capital Fund Reports Zero Beneficial Ownership in Sunshine Biopharma Inc.
Schedule 13G Amendment
Bigger Capital Fund L P, Bigger Capital Fund GP, LLC, and Michael Bigger have filed an amended Schedule 13G, indicating they no longer beneficially own any shares of Sunshine Biopharma Inc. common stock.
Summary
- Bigger Capital Fund L P, Bigger Capital Fund GP, LLC, and Michael Bigger (collectively, the "Reporting Persons") have filed an Amendment No. 1 to their Schedule 13G.
- As of June 11, 2025, the Reporting Persons beneficially owned 0.00 shares of Sunshine Biopharma Inc. common stock.
- This represents 0% of the class of securities.
- The filing certifies that the securities were not acquired or held for the purpose of changing or influencing the control of the issuer.
Sentiment
Score: 5
Explanation: The document is a factual regulatory filing reporting a change in beneficial ownership to zero, which is neutral in tone. While the divestment of a significant holder could be viewed negatively, the filing itself is purely informational.
Negatives
- The filing indicates that Bigger Capital Fund L P and its affiliates, previously a reportable shareholder, no longer hold any beneficial ownership in Sunshine Biopharma Inc., which could be interpreted as a divestment or reduction below the reporting threshold.
Future Outlook
The document does not provide any forward-looking statements or guidance from Sunshine Biopharma Inc. or the reporting entities regarding the issuer's future.
Industry Context
This filing is a standard regulatory disclosure indicating a change in a significant investor's stake. It does not provide broader industry trends or competitive analysis.
Stakeholder Impact
- Shareholders: May interpret the exit of a previously significant investor as a signal, potentially influencing sentiment or share price.
- Management: Provides clarity on the current ownership structure and the cessation of a previously reportable stake.
Key Dates
| Date | Description |
|---|---|
| 06/10/2025 | Date of event which required the filing of this statement (reduction of beneficial ownership). |
| 06/11/2025 | Date as of which the Reporting Persons owned no securities of the Issuer. |
| 06/12/2025 | Date the Schedule 13G Amendment No. 1 was signed and filed. |
Keywords
Sunshine Biopharma Inc., Bigger Capital Fund, Schedule 13G, Beneficial Ownership, SEC Filing, Common Stock, Institutional Investor, Divestment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.